Abstract
PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have